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ABSTRACT The binding of blockers to the human voltage-gated Kv1.5 potassium ion channel is investigated using a three-
step procedure consisting of homology modeling, automated docking, and binding free energy calculations from molecular
dynamics simulations, in combination with the linear interaction energy method. A reliable homology model of Kv1.5 is
constructed using the recently published crystal structure of the Kv1.2 channel as a template. This model is expected to be
signiﬁcantly more accurate than earlier ones based on less similar templates. Using the three-dimensional homology model,
a series of blockers with known afﬁnities are docked into the cavity of the ion channel and their free energies of binding are
calculated. The predicted binding free energies are in very good agreement with experimental data and the binding is predicted
to be mainly achieved through nonpolar interactions, whereas the relatively small differences in the polar contribution determine
the speciﬁcity. Apart from conﬁrming the importance of residues V505, I508, V512, and V516 for ligand binding in the cavity, the
results also show that A509 and P513 contribute signiﬁcantly to the nonpolar binding interactions. Furthermore, we ﬁnd that
pharmacophore models based only on optimized free ligand conformations may not necessarily capture the geometric features
of ligands bound to the channel cavity. The calculations herein give a detailed structural and energetic picture of blocker binding
to Kv1.5 and this model should thus be useful for further ligand design efforts.
INTRODUCTION
Voltage-gated K1 (Kv) channels are of fundamental impor-
tance for the function of excitable cells, such as neurons and
muscle cells (1). In the human heart, Kv channels are
speciﬁcally assigned the task of repolarizing the cell
membrane at the end of the action potential, by means of
the three delayed rectiﬁer currents: IKr, IKs, and IKur.
Prolongation of the action potential duration is a possible
way of preventing cardiac arrhythmia—therefore, blocking
of channels that perform the repolarization (i.e., lowering the
net repolarization current) can generally be expected to have
antiarrhythmic effects (2). The single most common serious
cardiac arrhythmia is atrial ﬁbrillation (AF), with a preva-
lence of almost 9% in ages 80–89 years (3). AF is known to
be a major risk factor for stroke and at present treatment of
AF is associated with potentially lethal side effects in the
form of ventricular proarrhythmia (4–8). A majority of the
available antiarrhythmic drugs target either IKr or both IKr
and IKs, which are present not only in the atria but in the
ventricles as well. Thus, the development of atrial-speciﬁc
antiarrhythmic drugs is of the utmost medical importance.
Among the three delayed rectiﬁer currents, IKur is the only
one present exclusively in the atrium (9–11). The ion channel
associated with IKur is Kv1.5, and inactivation of Kv1.5 by
antisense RNA has been found to lower IKur by as much as
50% (11–14). Kv1.5 is therefore considered a promising
target for atrial-speciﬁc antiarrhythmic drugs.
Like for most other known potassium channels, the
functional form of Kv1.5 is a homotetramer, with each
subunit consisting of six membrane-spanning helices, S1–S6
(15). Helices S1–S4 make up the voltage sensor, which
reacts to potential changes across the membrane and
regulates the gating of the channel through a still-debated
mechanism (16–18). The highly conserved selectivity ﬁlter
is located between S5 and S6, and is connected to S5 via the
pore helix and a short loop located outside the membrane
(Fig. 1 A). Together, S5, S6, the ﬁlter, and the pore helix
make up the pore of the channel, whose intracellular part is
arranged in what has been dubbed an ‘‘inverted teepee’’
cavity (19). The surface of this cavity is highly hydro-
phobic—the only hydrophilic residues on the cavity surface
are T479 and T480, which are located at the intracellular
entry to the selectivity ﬁlter. T479 and T480 are also the only
residues on the surface of the cavity that are not located in the
inner helix (S6). This intracellular pore cavity has been
identiﬁed as the binding site for a number of Kv1.5 blockers
(20–26), and ligands of the type studied here have been
shown to bind to, and block, the open state of the channel.
This conclusion is based on the rapid block of current during
a depolarization pulse and the enhancement by higher rates
of stimulation (26). Mutational experiments have identi-
ﬁed the S6 residues V505, I508, V512, and V516 along
with T479 and T480, as important residues for binding of
N-benzyl-N-pyridin-3-yl-methyl-2-(toluene-4-sulfonylamino)-
benzamide hydrochloride (S0100176) and 29-f[2-(4-me-
thoxy-phenyl)-acetylamino]-methylg-biphenyl-2-carboxylic
acid (2-pyridin-3-yl-ethyl)-amide (AVE0118) (25,26). Ad-
ditionally, the S6 residues T507, L510, and V514, as well as
T479, have been identiﬁed as potential binding sites for
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quinidine, bupivacaine, and benzocaine (22–24), and V505,
I508, L510, V512, and V516 have been shown to be in-
volved in binding of Kvb1.3 subunits (27).
With the recent publication of the open state Kv1.2 crystal
structure (28), it became possible to construct a very reliable
three-dimensional (3D) homology model of the selectivity
ﬁlter and pore of Kv1.5, since the sequence identity between
the two is ;90% in this region (Fig. 1 B). Using such a
model, computational methods can be used to investigate
and characterize the interactions between potential blockers
and the ion channel. Computational models for binding of
bupivacaine, S0100176, and AVE0118 to Kv1.5 have been
published earlier using the crystal structure of the much less
similar KcsA channel (;30% sequence identity in the ﬁlter
and cavity regions) as a template for the homology modeling
of Kv1.5 (25,26,29). The results from these studies are also
somewhat ambiguous, with fairly different binding modes
for the different ligands—in the study of S0100176, the
ligand conformation is very compact and it is predicted to
bind close to the selectivity ﬁlter (25), whereas the results
from the bupivacaine and AVE0118 studies indicate a more
stretched-out conformation of the ligand bound to the lower
part of the cavity, near the characteristic PVP motifs (26,29).
To our knowledge, no structural studies of Kv1.5 have been
published to date where the binding of several ligands are
addressed, and where calculated binding free energies are
compared to experimental values. The fundamental question of
what makes a potent Kv1.5 blocker thus remains unanswered.
The work presented here aims to further develop our
knowledge of the binding of ligands to the Kv1.5 ion
channel, in a manner similar to the work of O¨sterberg et al.
on the hERG channel (30). Binding modes and afﬁnities of
several ligands to the Kv1.5 channel are investigated in detail
by a combination of computational methods, using blocking
compounds and experimental binding data published by
Peukert et al. (31). Besides homology modeling of Kv1.5,
the procedure (Fig. 2) involves subsequent docking of
ligands to the model and, ﬁnally, reﬁnement of ligand poses
and free energy calculations using molecular dynamics (MD)
simulations together with the linear interaction energy (LIE)
method (29,30). This type of combination of automated
docking with force-ﬁeld-based free energy calculations has
become widely used for ligand binding predictions (32). The
calculated binding afﬁnities are in very good agreement with
experimental results, with a near-perfect correlation in
ranking of the ligand potencies. Furthermore, the results
indicate that the key ligand-protein interactions are the same
for all the studied ligands, and that they all bind in a similar
pose. Desolvation of the hydrophilic linkers of the ligands
is predicted to be the main discriminating factor separating
the strong blockers from the weaker blockers.
MATERIALS AND METHODS
Homology modeling
The modeling software Modeller 7v7 (33–35) was used to generate a 3D
homology model of the open state of the Kv1.5 channel, using the 2.9-A˚
crystal structure of the Kv1.2 channel (Protein Data Bank (PDB) accession
code 2A79 (28)) as a template. Helices S5 and S6 together with the
selectivity ﬁlter and the pore helix were included in the model. In this region,
the sequence identity between Kv1.2 and Kv1.5 is ;90%, and they align
without any gaps at all, which allows a very reliable homology model to be
constructed. The system was then prepared for docking and MD simulations
according to the procedure in Luzhkov et al. (36). An ;35-A˚-thick layer of
octane molecules was subsequently built around the model, using Packmol
(37), to emulate the membrane in which the ion channel is normally situated.
The octane layer/ion channel assembly was then solvated with TIP3P water
molecules (38) in a cubic periodic box with box length 77 A˚, and allowed to
FIGURE 1 The 3D homology model of Kv1.5, superimposed on the
Kv1.2 crystal structure (28) used as a template is shown in panel A. The pore
helix, selectivity ﬁlter, and the membrane-spanning helices S5 and S6 are
shown in purple, orange, cyan, and green, respectively. The side chains of
the residues proposed to be involved in ligand binding (22–26), i.e., T479,
T480, V505, T507, I508, L510, V512, and V514, are shown as sticks. Only
two subunits of the tetramer are shown for clarity. Panel B shows the
sequence alignment of the amino acid sequences of the pore region of
Kv1.2 (PDB accession code 2A79) and Kv1.5 (Swiss-prot entry P22406).
The color coding follows that in panel A. Residues in bold face have
been identiﬁed as potentially involved in binding of a number of blockers
(22–26).
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equilibrate for 500 ps in an MD simulation at 300 K. During this relaxation
all heavy atoms of the protein were subjected to 10 kcal/molA˚2 harmonic
positional restraints, to relieve possible bad contacts but keeping the
structure of the ion channel model intact, while allowing the solvent and
octane molecules to equilibrate around the channel assembly. This
procedure was thus employed to prepare a relaxed system for docking.
Docking
All ligands were energy minimized with the OPLS all atom force ﬁeld (39)
before docking. Automated docking of the ligands was performed using the
GOLD 3.0 software (40,41). GOLD uses a genetic algorithm (GA) in
combination with scoring functions to predict binding poses for ﬂexible
ligands in a rigid binding site. In the work described here, the ChemScore
scoring function was used exclusively (42). In addition to predicting the
binding pose, ChemScore also estimates the binding free energy of each
ligand pose, allowing the docking results to be compared directly with
experimentally determined binding afﬁnities. The active site radius was set
to 22 A˚, centered around a point on the symmetry axis of the channel;10 A˚
below the ‘‘roof’’ of the cavity—slightly above the PVP bend of the S6
helix. This positioning of the docking sphere enables the ligands to explore
different docking conformations within the entire cavity, which is rather
large and open at its intracellular side. Fifty GA runs were performed for
each ligand, where all variables for the GA were set to their default values.
GOLD was set to terminate the docking if the top three poses for a ligand
were within 1.5 A˚ root mean-square deviation (RMSD). The docking
procedure was performed with a water molecule present in the fourth
position of the selectivity ﬁlter, which is the only position that is relevant for
the cavity shape as seen by the docking algorithm (this position is also
occupied in the majority of crystal structures of potassium channels). All
other solvent molecules were thus removed from the system in the docking
calculations and, after poses for the bound ligands had been obtained, the
complexes were again solvated for molecular dynamics and free energy
calculations (Fig. 2).
Molecular dynamics and binding free
energy calculations
Binding afﬁnities were calculated using molecular dynamics in combination
with the linear interaction energy method, which uses simulations of the ligand
free in solution as well as of the protein–ligand complex to calculate the change
in free energy associated with binding to the protein (43). In the LIE method,
the difference in interaction energies between the ligand and its surroundings
is used to calculate the free energy of binding through the equation
DGbindLIE ¼ aDÆVvdWls æ1bDÆVellsæ1 g: (1)
Here, ÆVvdWls æ and ÆVellsæ are MD averages of the ligand-surrounding van
der Waals and electrostatic interaction energies, respectively, and D denotes
the difference between these averages in the bound and free states. The
empirical parameter a is used to scale the van der Waals energies, and in
earlier studies performed in our laboratory, an a-value of 0.18 has been able
to reproduce the binding free energies of ligands in a number of different
systems. The value of the ligand-dependent electrostatic parameter b is
determined by a simple set of rules (44). According to these rules, the value
of b is 0.43 for all ligands present in this study. To be able to reproduce
absolute binding free energies, a constant term g may be required, which has
been shown to be related to binding site hydrophobicity (45).
All MD calculations were carried out using the program Q (46) with the
OPLS all atom force ﬁeld (39). Partial atomic charges were assigned to the
ligands in analogy with the charges speciﬁed in the OPLS fragment library.
A 25-A˚ simulation sphere was used for both simulations in the bound and
free states. The 1010 loading state was used for the ion channel, i.e., a
potassium ion was present in the ﬁrst and third position of the selectivity
ﬁlter, in accordance with earlier results (29,47–49). The same sphere center
as described for the docking procedure was used, and the channel/ligand/
octane systems were again solvated with TIP3P water (38) (Fig. 2). Only one
ionizable residue per subunit (E433) was situated within 20 A˚ of the sphere
center. These were modeled in their negatively charged form, yielding a net
charge of2 e for all simulations of the ligands in the bound state. Note that
the ligands are neutral so that the energetic contributions from additional
charged (and surface-exposed) residues farther away is negligible.
All atoms outside the 25-A˚ sphere were tightly restrained throughout the
entire simulations. Water molecules at the surface of the sphere were
subjected to radial and polarization restraints to mimic the properties of bulk
water (50). Before data collection, each simulation system was heated in a
stepwise manner from 10 to 300 K with all solute heavy atoms subject to
strong (10–25 kcal/molA˚2) harmonic positional restraints. All simulations
of the ligands in the bound state were then equilibrated without restraints for
500 ps, followed by 250 ps of production phase MD. To assess the problem
of conformational sampling when simulating the ligands in the free state in
water, 10 replicate water simulations of 1 ns each were performed for each
ligand, with starting conformations generated by high temperature MD. For
all production phase MD, a 1-fs time step was used along with the SHAKE
procedure for all solvent bonds (51). Nonbonded interactions across the
simulation sphere boundary were excluded. A nonbonded cutoff of 10 A˚ was
used, with electrostatic interactions outside the cutoff treated with the local
reaction ﬁeld multipole expansion (52), except for the ligand, which had no
cutoff applied to any of its interactions.
RESULTS AND DISCUSSION
Binding of eight ortho,ortho-disubstituted bisaryl com-
pounds (Table 1) to the open state of the Kv1.5 channel
FIGURE 2 Overview of the computational procedure. In the ﬁrst step, a homology model of Kv1.5 (cyan) is constructed using a template structure (orange).
An octane membrane model (yellow) is then built around the ion channel and the system is equilibrated in water. In the next step, the water molecules are
removed and automated docking is used to ﬁt the ligands (purple) into the pore cavity. Finally, the complexes are solvated again for reﬁnement and free energy
calculations by molecular dynamics simulations, utilizing more efﬁcient reduced spherical systems.
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was investigated using a three-step procedure, consisting of
homology modeling, automated docking, and binding free
energy calculations from molecular dynamics simulations.
This enables a detailed structural analysis of binding modes
and identiﬁcation of the key ligand-protein interactions that
contribute to the free energy of binding. The simulated
compounds are a subset of the ligands for which experi-
mental binding afﬁnities have been published by Peukert
et al. (31), and were chosen to include both the least and most
potent inhibitors from that series, as well as displaying a
fairly wide variety of structural features. All ligands share a
common central biphenyl group, with substituents consisting
of aliphatic and aromatic hydrocarbons, pyridyl rings, and
primary amides, attached to the biphenyl group by amide,
carbamate, ester, and sulfonamide linkers.
Homology modeling
The homology model of Kv1.5 is structurally more or less
identical to the template, i.e., the pore region of the crystal
structure of Kv1.2 (PDB accession code 2A79), which is not
surprising, given the very high sequence identity in this
region (Fig. 1 B). Residues 417–527 (Kv1.5 numbering)
were included in the model, and the RMSD for the backbone
atoms of the model compared to the template was 0.35 A˚,
when a single subunit of the model was superimposed on the
crystal structure. For the residues that form the surface of
the pore cavity, and thus can be expected to be important for
correct docking and molecular mechanics interactions, the
RMSD of the model compared to the crystal structure is 0.34
A˚. The modeled structure is shown, together with the
template in Fig. 1 A, and as can be clearly seen in this ﬁgure,
the only part of the structure where the backbone of the
Kv1.5 model differs signiﬁcantly from the template is in the
immediate surroundings of D485. This is most likely caused
by the fact that the Cg, Sd, and Ce atoms of the adjacent
methionine residue are missing in the crystal structure,
forcing the modeling software to displace D485 somewhat to
accommodate the side chain of M486. However, these
residues are .20 A˚ away from the ligand binding site, and
are, in fact, outside the simulation sphere in both the
automated docking and molecular dynamics simulations. It
should also be emphasized here that Kv1.5 and the template
Kv1.2 have identical sequences in the cavity region so that
the problem of arbitrarily modeling initial (before MD) side-
chain rotamers does not really exist in this case. The situation
is, for example, much more difﬁcult in the case of the hERG
channel (30) where the rotameric states of several aromatic
residues have to be modeled in a more arbitrary way.
Automated docking
Each docking simulation generated 50 docked conforma-
tions of each ligand, except the docking of compound 17a,
for which the three top-ranked solutions were within 1.5 A˚
RMSD of each other after 37 poses had been generated. The
docking procedure generally generated slightly more diverse
docking poses for the compounds containing sulfonamide
groups (i.e., 7b and 7c), and to a lesser extent for the
compounds containing pyridyl rings (i.e., 17c and 17o).
Encouragingly, out of these 387 (¼7 3 50 1 37) poses
generated, only a handful fall outside of a consensus
orientation where the biphenyl part of the ligand is
TABLE 1 Compounds used in the simulations along with the
corresponding experimental IC50-values for human Kv1.5 (31)
Compound Structure Human Kv1.5 IC50 (mM)
7b 9.1
7c 11.2
15a 3.5
17a 0.8
17c 0.7
17f 8% inhibition at 10 mM
17g 3.3
17o 0.16
The ligand numbering is the same as in Peukert et al. (31).
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positioned in the PVP region of the cavity, in close proximity
to V512, P513, and V516. One of the substituents (generally
the largest one) is then pointing toward the selectivity ﬁlter,
typically in close contact with V505, I508, and A509.
Mutational studies have identiﬁed residues V505, I508,
V512, and V516 as important for Kv1.5 binding of two other
ligands, S0100176 and AVE0118 (25,26). However, the
results from the studies of S0100176 and AVE0118 indicate
little or no effect from mutations of A509 or P513.
Out of the top 10 ranking solutions for any given ligand,
taking only heavy atoms into account, the average RMSD
compared to the top-ranked solution was 2.5 A˚, with few
poses deviating .4 A˚ from the top-ranked pose. Typical
results are shown for ligand 17a in Fig. 3. Conformations
that deviated more did so because the orientation of the
substituents was ﬂipped with respect to the other poses,
whereas the biphenyl part remained in the same position.
Even for ligand 7b, which showed relatively large diversity
in the suggested binding poses, the positioning of the
biphenyl part of the ligand is very well determined—the
positions of the biphenyl carbons for all but seven poses (all
of which are among the 10 lowest ranked) are all situated
within the van der Waals surface of the top-ranked pose. The
smallest compound, 15a, showed the least deviation between
docking poses. The heavy atoms of the top 20 docking poses
were in this case all within 2.6 A˚ RMSD of the highest-
ranked pose, with a corresponding average RMSD of 1.6 A˚.
Note that because of the fourfold symmetry of the ion
channel cavity, all RMSD values for the docking poses were
calculated after rotating (in 90 increments) the docked poses
around the symmetry axis of the cavity to ﬁnd the orientation
with the maximum overlap with respect to the top-ranked
pose of the studied ligand.
Fig. 4 shows the correlation between the free energies of
binding for each ligand as estimated by Chemscore, and the
binding free energies derived from the experimentally
determined IC50-values of the ligands. The correlation
between the ﬁtness score and the estimate of the free energy
of binding is not entirely straightforward in Chemscore,
therefore, the top-ranked pose (with respect to ﬁtness score)
may not be associated with the lowest estimate of the free
energy of binding. In Fig. 4, the lowest of the binding free
energy estimates of the top ﬁve ranked poses for each ligand
is plotted against the differences in binding free energy
calculated from their experimentally determined IC50-values
(31). That is, we use here the common approximation
DGbindobs ’ RTln IC50; which can be expected to yield reliable
relative free energies whereas the absolute values are usually
somewhat too positive (i.e., IC50.Kd). A constant offset,
analogous to the LIE g-parameter, has been added to the
binding free energy estimates from Chemscore to obtain the
least-squares ﬁt with respect to DGbindobs : The Spearman rank
correlation coefﬁcient is 0.12, indicating a very weak
positive correlation between the calculated and observed
values of the binding free energies. If compound 7b is left
out of the calculation, the Spearman rank correlation coef-
ﬁcient increases to 0.43, which is signiﬁcantly stronger, but
still indicates a fairly weak positive correlation.
FIGURE 3 Top 10 docking solutions for compound 17a. The average
heavy atom RMSD relative to the top-ranked pose is 1.4 A˚. Note that some
of the solutions have been rotated 90, 180, or 270 around the symmetry
axis of the pore, because of the fourfold redundancy introduced by the
symmetry of the ion channel.
FIGURE 4 The correlation between the free energies of binding of ligands
7b–17o as calculated by Chemscore (DGbindCS ) (42) versus those experimen-
tally determined by Peukert et al. (DGbindobs ) (31).
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Molecular dynamics
For each ligand, the top ﬁve binding poses from the auto-
mated docking experiments were chosen for further inves-
tigation using molecular dynamics. Out of these 40 poses, all
but one had the biphenyl part of the ligand positioned in the
PVP region of the cavity. Generally, the ligand positions are
stable during MD simulation, and the average structures
from the production phase MD deviates relatively little from
the docked positions (Figs. 5 and 6). The average RMSD of
the heavy atoms of the poses shown in Fig. 5, compared to
their corresponding docked poses, is 2.1 A˚. The hydrophilic
linkers have little or no speciﬁc interactions with the protein,
and are thus fairly ﬂexible during the MD simulations,
whereas the hydrophobic parts of the ligand are typically
more stable in their positions—sometimes alternating be-
tween equivalent sites on the tetrameric channel assembly
(consider, e.g., the pyridyl group of ligand 17c in Fig. 5,
which is rotated roughly 90 about the symmetry axis of the
cavity between the docked and MD average poses).
For each ligand, the nonpolar ligand-protein interactions
were calculated and grouped by contributions from each
residue of the protein (Fig. 7). On the one hand, the results of
these calculations strongly support the earlier alanine
scanning results of Decher et al. (25,26)—that V505, I508,
V512, and V516 are important for Kv1.5 ligand binding. On
the other hand, the results indicate that for all of the ligands,
the largest or second largest contribution to the nonpolar
interaction energy comes from either A509 or P513. This
might at ﬁrst appear to be at variance with the results
presented by Decher et al., where the A509V and P513A
mutants had little or no effect on binding of the compound
AVE0118 (26). However, our model suggests that both of
these mutations can be accommodated without displacing
the bound ligands (Fig. 6), consistent with the possibility that
both the native and mutant channels have favorable contri-
butions from these residues.
Also, T480, which was the single most important residue
for binding in both previous studies (25,26), shows some
contribution to the nonpolar ligand-protein interactions, but
smaller than the other residues mentioned above. This is
FIGURE 5 Comparison between the
average structures from the production
phase MD simulations in the bound
state (green) and the corresponding
docking poses (gray) used as starting
conformations for the MD simulations.
The average structures shown are from
the simulations that yielded the lowest
estimated free energy of binding.
FIGURE 6 Molecular dynamics average structure of ligand 17a bound
to the Kv1.5 ion channel. Protein residues within 4 A˚ of the ligand are shown
as sticks. One channel subunit has been removed for clarity.
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FIGURE 7 The contribution of each protein residue to the ligand-protein Lennard-Jones interaction energy. Because of the fourfold symmetry of the ion
channel, the value of the interaction energy for a given residue number is the sum of the contributions from each of the four corresponding protein residues.
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perhaps not surprising, considering that the threonine
residues do not present many possibilities for signiﬁcant
hydrophobic contributions. However, the polar interactions
between the ligands and T480 are equally weak, refelecting
the fact that these ligands all bind with a nonpolar moiety
pointing toward T480. This is in contrast to the most similar
compound examined by Decher et al. (26), AVE0118, which
according to our model would have its methoxy group in
contact with the threonine side chains. All high-ranking
solutions from additional dockings of that ligand consis-
tently places the methoxy group in such a way. Hence, the
large effect of the T480A mutation may reﬂect interactions
with this speciﬁc group of the AVE0118 blocker, which is
not present in any of the compounds in our set. It is also
evident (Fig. 6) that the T480 side chains contribute in
deﬁning the upper part of the ligand binding cavity. This
could mean that their contribution to ligand binding is
mainly steric and that the T480A mutation would remove
key restrictions leading to our consensus binding mode.
It is also interesting to note that the polar interactions
between the ligands and the protein are generally much
weaker than the nonpolar interactions. This is mainly due to
the hydrophobic nature of the cavity and to the fact the
ligands are neutral and only weakly dipolar. Among all of the
ligands the only electrostatic interaction energy stronger than
2 kcal/mol is the interaction between compound 17a and
residue I508. It is further noteworthy that throughout all of
the 40 MD simulations, not a single stable hydrogen bond is
formed between either of the ligands and the protein.
Binding free energies
The correlation between the lowest calculated free energy of
binding (obtained from LIE and MD) for each ligand and the
relative free energy differences derived from the experimen-
tally determined IC50-values is very good (Table 2 and Fig. 8
A). Using the standard values of the a- and b-parameters in
the LIE equation (44), the average unsigned error of the
calculated binding free energies is 0.7 kcal/mol. The ranking
of the ligands is also in very good agreement with ex-
periment, with a Spearman rank correlation coefﬁcient of
0.83. Compound 17f is excluded from Fig. 8 and in the
calculation of the average unsigned error, but included in the
calculation of the Spearman rank correlation coefﬁcient since
the results in Peukert et al. (31) indicate that 17f is a weaker
blocker than both 7b and 7c, although no IC50-value was
reported. If 17f is left out of the ranking according to binding
free energies obtained by LIE, the Spearman rank correlation
coefﬁcient increases slightly to 0.86.
The correlation between the calculated and experimental
binding free energies may be further improved by using
separate b-parameters for the electrostatic interaction ener-
gies in the bound and free states (44,53). Using the standard
b-value of 0.43 for the free state and allowing the b-value for
the bound state to be treated as a free parameter and
performing a least-squares optimization with respect to the
experimental values yield a bound state b of 0.48. The ﬁt is
somewhat improved (Fig. 8 B) and the average unsigned
error decreases to 0.3 kcal/mol, whereas the Spearman rank
correlation coefﬁcient increases to 0.93. The increased
Spearman rank correlation coefﬁcient is largely a result of
the calculated binding free energy of ligand 17f decreasing
from 7.5 to 6.4 kcal/mol when using a bound state b of
0.48, resulting in a drop in ranking from the third least potent
to the least potent compound. It is interesting to note that
although the data for compound 17f are not used in the
optimization of b, since there is no explicit experimental data
to ﬁt to, the effect of using a bound state b of 0.48 when
calculating its free energy of binding is consistent with the
experimental results in Peukert et al. (31).
It is also interesting to examine how predicted binding free
energies are affected by the quality of the homology model
of the Kv1.5 channel. To address this issue we constructed a
homology model based on the crystal structure of KcsA
(PDB accession code 1K4C) (54) using the same procedures
as for the Kv1.2-based model. The sequence alignment with
respect to KcsA is given in Luzhkov et al. (29). Docking and
MD simulations were then carried out for the entire ligand
TABLE 2 Ligand-surrounding energies and calculated binding free energies from the MD simulation resulting in the lowest binding
free energy for each ligand
ÆVvdWls æf ÆVvdWls æb ÆVellsæf ÆVellsæb DGbindLIE DGbindobs (31)
7b 38.4 6 0.3 67.3 6 0.4 78.5 6 1.5 70.4 6 1.2 5.2 6 1.3 6.9
7c 34.8 6 0.2 62.7 6 0.1 73.6 6 1.7 68.0 6 0.1 6.1 6 0.8 6.8
15a 35.5 6 0.2 53.6 6 0.4 27.6 6 0.5 31.1 6 0.8 8.2 6 0.6 7.5
17a 38.5 6 0.3 60.8 6 1.2 32.3 6 0.9 36.6 6 0.6 9.4 6 0.9 8.4
17c 40.0 6 0.3 65.0 6 0.0 38.7 6 0.7 39.9 6 0.4 8.5 6 0.5 8.4
17f 38.9 6 0.3 66.4 6 0.2 24.5 6 0.9 22.4 6 0.2 7.5 6 0.5 N/A*
17g 36.7 6 0.2 61.7 6 0.7 28.7 6 0.3 29.3 6 0.5 8.3 6 0.5 7.5
17o 42.4 6 0.4 69.9 6 0.4 40.7 6 0.8 42.8 6 0.2 9.3 6 0.5 9.3
All values are in kcal/mol. Ææf and Ææb denote interaction energy averages for the free and bound states of the ligand, respectively. Errors are calculated as half
of the difference between the averages of the ﬁrst and second half of the data collection trajectory. Observed binding free energies are derived from
DGbindobs ’ RTln IC50; with a 1 M standard state. A g-value of 3.47, obtained from a least-square ﬁtting of the calculated binding free energies (not including
17f) to DGbindobs ; was used to calculate DG
bind
LIE .
*No IC50-value is available for compound 17f in Peukert et al. (31); see also Table 1.
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data set as described above. It was immediately apparent
from the new docking calculations that these solutions
generally showed a larger spread with higher RMSD values
than for the more accurate Kv1.2 model (for which an
example is given in Fig. 3). This indicates that the binding
modes become less well deﬁned for a channel model based
on KcsA, which would also be the expectation for an
erroneous model. Furthermore, the calculated binding free
energies from subsequent MD simulations show almost no
correlation with the experimental values, even if the constant
term (g) is optimized to ﬁt the absolute experimental values
(Fig. 8 C). Also, a 4 kcal/mol more negative constant term is
required in that case, suggesting signiﬁcantly weaker absolute
binding afﬁnities than for the Kv1.2-based model. The
average unsigned error of the calculated binding free energies,
in fact, increases by .300% with the less accurate model
based on KcsA (data not shown). These results thus serve as a
negative control for our Kv1.2-based model and demonstrate
that the quality of the homology modeling template is indeed
important for obtaining reliable binding free energies.
Although, as noted in the previous section, the electro-
static interactions between the protein residues of the channel
cavity and the ligands are relatively weak, they play a key
role in determining the binding afﬁnities of the ligands. In
fact, the ranking according to DÆVellsæ is identical to the
ranking according to DGbindLIE ; with the exception of com-
pound 15a. This ligand also has signiﬁcantly less hydrophilic
substituents compared to the other ones and the electrostatic
interactions may thus be expected to contribute relatively
more to binding. That is to say, although the nonpolar inter-
actions give a larger overall contribution to the calculated
binding free energies, that contribution is relatively uniform
for the different ligands. In contrast, the larger differences
in the electrostatic or polar contributions are more impor-
tant in determining the relative potency of the ligands. If
only ligand-water interactions are taken into account, a
clear picture emerges where the two sulfonamide-contain-
ing compounds 7b and 7c both lose ;15–20 kcal/mol in
electrostatic interaction energy with water when going from
the free state to the bound state, whereas the rest of the li-
gands have roughly as strong polar interactions with water
both in the free and the bound state. The two ligands with
the highest calculated binding afﬁnities, compounds 17a
and 17o, even have stronger electrostatic ligand-water inter-
actions in the bound state than in the free state. It is ob-
vious that the sulfonamide groups of compounds 7b and
7c, which have hydrogen bond donors and acceptors
pointing in three different directions in addition to being
shielded by a bulky naphthalene group, have a hard time
ﬁnding enough solvent or protein hydrogen bond partners
in the hydrophobic cavity. It is perhaps less obvious how
the amide, carbamate, and ester groups of compounds
15a–17o manage to maintain their interactions with cavity
waters in the bound state, but they are clearly sufﬁciently
small and solvent exposed to do so. From this point of
FIGURE 8 The correlation between the free energies of binding of ligands
7b–17o as calculated by molecular dynamics in combination with the LIE
method (DGbindLIE ) versus those derived from the experimental data of Peukert
et al. (DGbindobs ) (31). Two different LIE models are shown where panel A is
the standard model of Hansson et al. (44), whereas the model in panel B has
the electrostatic coefﬁcient b for the protein optimized against the
experimental data (see text). The lowest binding free energy estimate from
the ﬁve different poses simulated for each ligand is plotted against the
corresponding value calculated from experimentally determined IC50-values
(31). Panel C shows the corresponding correlation for the calculated binding
free energies from simulations of a homology model based on KcsA. Note
that a signiﬁcantly lower value of the constant g of 7.85 is needed to ﬁt
these data to DGbindobs ; indicating considerably weaker absolute binding.
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view, the relatively high calculated binding afﬁnity for
compound 17f is not surprising, given its similarity to 17g
and 17a, and the similar binding poses suggested by the
docking procedure. In fact, based solely on the differences
in structure between 17a, 17f, and 17g one might even sug-
gest that, given the nature of the binding site, 17f would be
expected to be the best blocker of the three. Since 17a and
17f are identical apart from the amide linker in 17a and the
ester linker in 17f, and the binding site is a highly hydro-
phobic but water-ﬁlled cavity, the less polarized ester linker
would be less sensitive to desolvation than the amide linker.
CONCLUSIONS
Herein, we have reported homology modeling, automated
docking of ligands, and binding free energy calculations
from molecular dynamics simulations of the open state of the
human Kv1.5 K1 ion channel. The 2.9-A˚ crystal structure of
the very closely related Kv1.2 channel was used as a
template for the homology modeling. Automated docking of
eight ortho,ortho-disubstituted bisaryl compounds with
known binding afﬁnities was performed using the resulting
3D model. For the top ﬁve docking solutions for each ligand,
the structural and thermodynamic stabilities of the docked
complexes were further investigated using the LIE method in
combination with MD simulations. The results from these
simulations strongly suggest that all of the ligands bind to the
Kv1.5 channel in a similar manner—with the biphenyl group
of the ligands situated near the PVP bend of the S6 helices in
the channel pore, and the larger of the two substituents
pointing toward the selectivity ﬁlter. Out of the 387 sug-
gested docking poses generated by automated docking, only
a handful are positioned in a signiﬁcantly different manner
than the top-ranked poses—and the deviating poses are
typically among the lowest ranked for that ligand. Further-
more, the ligands are found to be structurally stable in their
docked positions during unrestrained MD simulations.
Although the binding free energy estimates and the
implied ranking of the ligands obtained from the MD/LIE
simulations are in very good agreement with experiment, the
corresponding binding free energies and ligand ranking as
estimated by the Chemscore function during the docking
procedure shows little correlation with experimental data.
This highlights the usefulness of the combination of
automated docking and MD/LIE where the latter method
will typically yield reliable binding free energy estimates,
provided that the docking procedure generates reasonable
binding poses. The reasons for why the simpliﬁed LIE
approach is able to accurately describe binding in complex
systems has been discussed in several recent works
(45,53,55,56,57) and derive from a sound physical model
of the (solvation) free energies of ligands in their bound and
free states. It should, however, be noted that the more
rigorous free energy perturbation and thermodynamic inte-
gration methods, that for many years have been considered
too impractical and time consuming for binding calculations,
have recently reemerged as promising tools (58–60). This is
due both to increasing computational power and algorithmic
development.
Although the simulations conﬁrm the proposed signiﬁ-
cance of residues V505, I508, V512, and V516 for binding
of ligands to Kv1.5, there is an apparent disagreement
between the results presented herein and those of Decher
et al. regarding mutations of A509 and P513 (25,26). That is,
the results from alanine-scanning experiments of the pore
region of Kv1.5 showed that the mutations A509V and
P513A caused only very slight changes in ligand afﬁnity for
the compounds S0100176 and AVE0118. Although the
former blocker is signiﬁcantly different from those studied
herein, AVE0118 shares the same scaffold and would most
likely adopt the same binding mode as predicted by our
calculations (additional dockings of AVE0118 conﬁrm this
result). This does, however, not necessarily mean that the
interactions between the ligand and residues A509 and P513
are unimportant for binding. Since both A–V and P–A mu-
tations are relatively moderate changes with respect to the
possibilities of hydrophobic interactions with the side chains,
it could be possible for a ligand to have nearly equally strong
hydrophobic interactions with all three types of side chains.
That is to say, while mutating large hydrophilic or charged
residues into alanine will obviously have a signiﬁcant effect
on the afﬁnity of a ligand if the mutated residue is speciﬁ-
cally involved in binding, this may not be the case for resi-
dues whose side chains are more structurally similar to the
single methyl group of alanine. Furthermore, our model
suggests that the A509V and P513A mutations can be ac-
commodated without actually displacing the ligands. Thus, it
is perhaps not surprising that these mutations do not result in
a signiﬁcant loss of afﬁnity as the mutated side chains may
be similar enough to maintain hydrophobic interactions with
the ligand. The T480A mutation, on the other hand, was
found experimentally to have a large effect on the binding of
AVE0118, but the threonines give rather modest contri-
butions to the binding free energy in these simulations.
Our model, however, predicts that the methoxy group of
AVE0118, which is not present in any of the compounds
studied here, would indeed be in contact with the threonines.
Based on the type of ligands studied herein, as well as
meta-substituted benzene sulfonamides, a pharmacophore
model for lead identiﬁcation of Kv1.5 blockers has been
suggested by Peukert et al. (31,61). This pharmacophore
model consists of three hydrophobic centers in a triangular
arrangement, with the distances between the hydrophobic
centers being 12.62, 6.56, and 6.58 A˚. For the ligands
investigated in this work, this pharmacophore corresponds to
a fairly stretched-out conformation, where the large hydro-
phobic groups of both substituents are roughly at an equal
distance from the central biphenyl group. Indeed, the li-
gands do adopt this conformation in the free state (data not
shown) but, as can be clearly seen in Fig. 5, the bound state
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conformations of the ligands are generally much less elon-
gated. This illustrates a fundamental problem with deriving
pharmacophores from optimized isolated ligand structures,
as opposed to utilizing information regarding receptor-bound
ligand conformations. The former type of pharmacophore
model may fail to take into account conformational changes
that the ligands undergo upon binding to the receptor. It is
thus a general problem with ‘‘ligand-only’’ pharmacophore-
based drug design that it is possible to imagine a compound
that would satisfy the criterions of such a pharmacophore
model, yet have little or no afﬁnity for the binding site.
Similarly, it is possible to envision a strong blocker that does
not at all comply with the pharmacophore model. The
conclusion is therefore that ligand-based pharmacophore
searches for blocking compounds are likely to be hampered
both by returning false positives and false negatives. A more
fruitful strategy should thus be to utilize homology modeling
together with docking to derive 3D pharmacophore models
that incorporate information about the receptor.
In this work, the predicted binding modes to Kv1.5 are
strongly supported by the following facts: i), the high
sequence identity between Kv1.5 and Kv1.2 in the pore
region, ii), a consensus docking pose for all compounds,
which is also found to be stable during MD simulations, and
iii), an excellent correlation between observed and calculated
binding afﬁnities, where the latter were obtained from de-
tailed all-atom energetic calculations. Furthermore, a nega-
tive control, provided by simulations of the ligand series
utilizing a less accurate homology model based on KcsA,
showed that such a model does not yield good correlation
with experimental binding afﬁnities. This model for blocker
binding to Kv1.5, based on the Kv1.2 template, is thus one of
the few currently available examples of detailed 3D models
for how drug-like compounds interact with ion channels.
This work was supported by a grant from the Swedish Research Council (VR).
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